Alglucosidase alfa - Pharmacy benefit management
This medication was approved for use in patient’s ≥ 8 years old without cardiac hypertrophy suffering from late-onset Pompe disease.1 Pompe disease, also referred to as glycogen-storage disease type II or acid-maltase deficiency, is an autosomal recessive disease causing a deficiency in the lysosomal enzyme acid alpha-glucosidase (GAA). ................
................
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related searches
- allegiance benefit plan management cigna
- allegiance benefit plan management provider
- employee benefit management provider portal
- employee benefit management services
- allegiance benefit plan management provider portal
- employee benefit management service insurance
- benefit management services provider portal
- allegiance benefit management provider portal
- allegiance benefit plan management forms
- allegiance benefit plan management inc
- employee benefit management services inc
- benefit and risk management insurance